Search Results - N. Domper-Rubio

DP066 | UPDATED SAFETY RUN-IN RESULTS FROM LOTIS-5: A PHASE 3, RANDOMIZED TRIAL OF LONCASTUXIMAB TESIRINE WITH RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL/HGBL by C. Carlo-Stella, M. T. Kwiatek, J. Depaus, S. Grosicki, S. Snauwaert, E. Kingsley, J. López-Jiménez, B. Sanchez-Gonzalez, A. Urban, A. Niewiarowski, N. Domper-Rubio, L. Wang, E. Tiecke, M. Toukam, M. Hamadani

Get full text